Harsahaj Singh Wilkhoo | Neurology | Best Scholar Award

Mr. Harsahaj Singh Wilkhoo | Neurology | Best Scholar Award

Mr. Harsahaj Singh Wilkhoo, Tbilisi State Medical University, Georgia

Harsahaj Singh Wilkhoo is a dynamic and passionate final-year medical student at Tbilisi State Medical University. He has consistently demonstrated academic excellence, maintaining a GPA above 3.4, and actively engaging in medical education, research, and global healthcare innovation. As the founder and director of ClinNova International, he has empowered over 1,000 international medical students through mentorship, symposiums, and research workshops. His past leadership at GCMER Georgia impacted more than 10,000 students and professionals across 11+ countries. He is a certified Diabetes Educator by the International Diabetes Federation and an active member of the American College of Lifestyle Medicine. With 22+ research contributions, peer-reviewed publications, and conference presentations, his interests span neurology, endocrinology, stroke, and lifestyle medicine. A peer reviewer for academic journals, he envisions a future where interdisciplinary collaboration and AI will reshape global medical education and patient care.

Profile

Scopus

Orcid

Summary of Suitability:

Harsahaj Singh Wilkhoo exemplifies the essence of a “Best Scholar” through a rare combination of academic rigor, leadership, research engagement, and social impact. As a senior medical student at Tbilisi State Medical University, his sustained GPA of over 3.4 reflects his consistent academic performance. However, his true scholarly distinction lies beyond grades—in his bold initiatives that have transformed student research and peer learning on a global scale.

As the Founder and Director of ClinNova International, he has established a pioneering peer education and research platform that has empowered over 1,000 medical students in just six months. His role in organizing major academic events and nurturing clinical and research skills among cohorts of students positions him as a visionary mentor in the global medical education ecosystem. His earlier tenure as President of GCMER Georgia further highlights his leadership in building operational teams, launching campus initiatives, and organizing national and international academic conferences with far-reaching impact.

🎓 Education 

Harsahaj Singh Wilkhoo is currently pursuing his final semester in the M.D. program at Tbilisi State Medical University, Georgia, where he maintains a GPA exceeding 3.4. His education reflects a strong foundation in clinical sciences, medical ethics, and research methodology. His academic journey is marked by active participation in various student-led research clubs, academic fairs, and national student surgical conferences. He has received extensive training in clinical skills and has developed a particular focus on stroke, endocrinology, and lifestyle-related neurological disorders. Harsahaj has also completed international certifications, notably from the International Diabetes Federation School of Diabetes, which equipped him with advanced knowledge in diabetes management. He complements his formal education with online mentorship programs and research training cohorts that he organizes and leads. Through his educational journey, he continuously integrates theoretical learning with practical experience and global health exposure.

💼 Professional Experience 

Harsahaj Singh Wilkhoo is the Founder and Director of ClinNova International, a platform that fosters peer education and research among global medical students. Since 2024, he has managed a diverse team of 76 medical professionals, conducted workshops, and led events such as Cardioqest Symposium 2025 and Orthoconvergence 2025. He formerly served as President of GCMER Georgia (2021–2024), organizing large-scale academic events, mentoring over 1,000 students, and coordinating with 10+ universities. His earlier contributions include mentoring for GCMER HQ’s Journal Club, and working with the TSMU Academic Department where he organized major student-centered academic fairs and conferences. He is also a peer reviewer for Cureus Journal of Medical Science, and has freelanced as a proofreader/editor via Fiverr. Harsahaj excels in event execution, research mentorship, clinical education, and strategic leadership. His multidisciplinary roles highlight a rare blend of vision, initiative, and collaborative excellence.

🏅 Awards and Recognition 

Harsahaj Singh Wilkhoo has earned widespread recognition for his leadership and educational impact in international medical communities. Under his leadership, ClinNova International and GCMER Georgia have received acclaim for large-scale medical symposiums and research mentoring events, including Elixir 2023 and IMAUC 2023. He was certified as a Diabetes Educator by the International Diabetes Federation, Belgium, and his contributions have been highlighted in academic and public health discussions. He has organized over 10 flagship symposiums across diverse topics such as Onconexus, DiaConnect, and Neuro 2023, with hundreds of participants and over 100 research abstracts/posters showcased. He has also served as a peer reviewer for Cureus and other journals—an acknowledgment of his academic maturity and research insight. Through his mentorship and research training programs, he has impacted the careers of more than 1,000 medical students globally. His awards reflect dedication, interdisciplinary leadership, and academic contribution.

🌍 Research Skills On Neurology

Harsahaj Singh Wilkhoo possesses advanced research skills developed through involvement in over 22 research projects, peer-reviewed publications, and conference presentations. His expertise spans from neurological disorders and stroke to diabetes, cardiology, medical tourism, and lifestyle medicine. He has trained numerous students in research methodology, literature review, data analysis, scientific writing, and publication processes. As a peer reviewer at Cureus, he brings critical appraisal skills and editorial insight. He has hosted multiple abstract writing and poster presentation competitions, strengthening his skills in academic communication and event evaluation. Harsahaj leads research training cohorts that build capacity among students to publish and present in international conferences. His work reflects a keen understanding of clinical epidemiology, biostatistics, and ethical compliance. He believes in integrating artificial intelligence and interdisciplinary methods to solve healthcare challenges. His strategic approach, technical depth, and mentoring ability distinguish him as a research-oriented medical innovator.

📖 Publication Top Notes

Chandipura Vesiculovirus: Clinical Manifestation, Neuroinvasion and Public Health Interventions

  • Author(s): Harsahaj Singh Wilkhoo

  • Citation: Wilkhoo, H. S. (2024). Chandipura Vesiculovirus: Clinical Manifestation, Neuroinvasion and Public Health Interventions. International Journal of Health Sciences and Research.

  • Year: 2024 (Published on 2024-09-02)

Depersonalization-Derealization Disorder: Etiological Mechanism, Diagnosis and Management

  • Author(s): Harsahaj Singh Wilkhoo, Afra Wasama Islam, Felcia Reji, Rhea Potdar, Labdhi Sanghvi, Siddhant Solanki

  • Citation: Wilkhoo, H. S., Islam, A. W., Reji, F., Potdar, R., Sanghvi, L., & Solanki, S. (2024). Depersonalization-Derealization Disorder: Etiological Mechanism, Diagnosis and Management. Discoveries Journal.

  • Year: 2024 (Published on 2024-07-13)

Comparison of Impact of High versus Low FODMAPs diet on Gut Flora in Patients with Irritable Bowel Syndrome

  • Author(s): Afra Wasama Islam, Harsahaj Singh Wilkhoo

  • Citation: Islam, A. W., & Wilkhoo, H. S. (2024). Comparison of Impact of High versus Low FODMAPs diet on Gut Flora in Patients with Irritable Bowel Syndrome. International Journal of Progressive Sciences and Technologies.

  • Year: 2024 (Published on 2024-07-02)

Association of gut dysbiosis with potential mechanisms leading to atrial fibrillation: A narrative review

  • Author(s): Harsahaj Singh Wilkhoo

  • Citation: Wilkhoo, H. S. (2024). Association of gut dysbiosis with potential mechanisms leading to atrial fibrillation: A narrative review. International Journal of Innovative Science and Research Technology.

  • Year: 2024 (Published on 2024-05-16)

 

 

Dalia Saleh | Neurotoxicology | Best Researcher Award

Prof. Dr. Dalia Saleh | Neurotoxicology | Best Researcher Award

Prof. Dr. Dalia Saleh, National Research Centre, Egypt

Dr. Dalia Osama Abd El Fattah Saleh is a distinguished Egyptian pharmacologist renowned for her extensive research in neurotoxicology, diabetes, and cardiovascular diseases. She earned her Ph.D. in Pharmacology from Cairo University in 2012, focusing on estrogen's effects on vascular changes in insulin-resistant rats. Currently, she serves as an Assistant Professor at the National Research Centre in Cairo, contributing significantly to the field of pharmacology. Dr. Saleh has published numerous articles in reputable journals, highlighting her expertise in molecular pharmacology and toxicology. Her work has garnered over 1,700 citations, reflecting her impact on the scientific community. Beyond research, she has played pivotal roles in quality assurance, aiding her department in achieving ISO certifications. Dr. Saleh's dedication to advancing medical science and mentoring the next generation of researchers underscores her commitment to excellence in pharmacological research.

Professional Profile

Scopus

Orcid

Google Scholar

Suitability Summary for Best Researcher Awards

Based on the provided profile, Dr. Dalia Osama Abd El Fattah Saleh demonstrates substantial qualifications that make her highly suitable for the Research for Best Researcher Award. Her extensive academic background, with a Ph.D. in Pharmacology from Cairo University and over two decades of progressive research experience at the National Research Centre, positions her as a prominent candidate in the field of pharmacological research.

Dr. Saleh’s scholarly journey reflects a strong focus on translational and experimental pharmacology, with particular emphasis on diabetes, cardiovascular diseases, hepatic disorders, and neuropharmacology. Her role progression from Research Assistant to Assistant Professor and Researcher underlines a sustained commitment to scientific advancement. Notably, her leadership in quality assurance and ISO accreditation projects at the NRC demonstrates her organizational impact and dedication to research excellence.

Education 

Dr. Dalia Saleh's academic journey is marked by a steadfast commitment to pharmacological sciences. She obtained her Bachelor of Science in Pharmacy from Cairo University in 2002, graduating with honors. Pursuing advanced studies, she earned her Master of Science in Pharmacology in 2009, with a thesis investigating the effects of rosiglitazone on vascular and biochemical changes in diabetic rats. Her academic pursuits culminated in a Ph.D. in Pharmacology in 2012, where her research delved into estrogen's potential impact on vascular changes associated with insulin resistance in ovariectomized rats. Throughout her educational tenure, Dr. Saleh demonstrated a profound interest in understanding the intricate mechanisms of drug actions and their physiological implications. Her rigorous academic training laid a robust foundation for her subsequent research endeavors, enabling her to contribute significantly to the fields of neuropharmacology and toxicology. Dr. Saleh's educational background reflects her dedication to advancing medical knowledge and improving therapeutic strategies.

Professional Experience 

Dr. Dalia Saleh's professional career spans over two decades, characterized by her contributions to pharmacological research and education. Since 2003, she has been affiliated with the National Research Centre in Cairo, ascending from Research Assistant to Assistant Professor. Her roles have encompassed conducting pivotal research in pharmacology, with a focus on neurotoxicology and metabolic disorders. Dr. Saleh has also been instrumental in quality assurance, leading her department to achieve ISO 9001/2008 and ISO/IEC 17025/2005 certifications, reflecting her commitment to excellence and standardization in research practices. In academia, she has served as a part-time instructor at MSA University and the University of Sadat City, imparting knowledge in pharmacology and supervising student research projects. Her professional journey is marked by a blend of research acumen and dedication to education, positioning her as a respected figure in the pharmacological community. Dr. Saleh's multifaceted experience underscores her role in advancing pharmacological sciences and mentoring future researchers.

Awards and Recognition 

Dr. Dalia Saleh's exemplary work in pharmacology has earned her recognition within the scientific community. Her research contributions, particularly in neurotoxicology and metabolic disorders, have been widely cited, reflecting the impact of her work. She has actively participated in numerous national and international conferences, sharing her findings and collaborating with fellow researchers. Dr. Saleh's commitment to quality in research is evident through her leadership in achieving ISO certifications for her department, a testament to her dedication to excellence. Additionally, her involvement in various workshops and seminars underscores her role in continuous professional development and knowledge dissemination. While specific awards are not detailed, her professional trajectory and contributions signify a career marked by recognition and respect in the field of pharmacology. Dr. Saleh's achievements highlight her as a leading figure in advancing pharmacological research and education.

Research Skills On Neurotoxicology

Dr. Dalia Saleh possesses a comprehensive skill set in pharmacological research, with a particular emphasis on neurotoxicology, diabetes, and cardiovascular diseases. Her expertise encompasses in-vitro pharmacological techniques, molecular pharmacology, and toxicological assessments. She is proficient in conducting complex experiments involving animal models, such as ovariectomy procedures in rats, to study hormonal impacts on vascular functions. Dr. Saleh's research also delves into the biochemical pathways affected by various pharmacological agents, enabling a deeper understanding of drug mechanisms. Her ability to integrate molecular biology with pharmacology allows for a holistic approach to studying disease processes and potential treatments. Furthermore, her involvement in quality assurance and standardization of laboratory practices demonstrates her commitment to research integrity and reproducibility. Dr. Saleh's research skills are further evidenced by her extensive publication record, contributing valuable insights to the scientific community and advancing the field of pharmacology.

  Publication Top Notes

  • Title: HPLC-DAD-MS/MS profiling of phenolics from Securigera securidaca flowers and its anti-hyperglycemic and anti-hyperlipidemic activities
    Authors: RM Ibrahim, AM El-Halawany, DO Saleh, EMBE Naggar, ...
    Citation: Revista Brasileira de Farmacognosia, 25, 134–141
    Year: 2015
    Citations: 181

  • Title: Effects of sulforaphane on D-galactose-induced liver aging in rats: Role of keap-1/nrf-2 pathway
    Authors: DO Saleh, DF Mansour, IM Hashad, RM Bakeer
    Citation: European Journal of Pharmacology, 855, 40–49
    Year: 2019
    Citations: 63

  • Title: Antiviral Activity of Zinc Oxide Nanoparticles Mediated by Plumbago indica L. Extract Against Herpes Simplex Virus Type 1 (HSV-1)
    Authors: MM Melk, SS El-Hawary, FR Melek, DO Saleh, OM Ali, MA El Raey, ...
    Citation: International Journal of Nanomedicine, 8221–8233
    Year: 2021
    Citations: 58

  • Title: Synthesis, vasorelaxant activity, and molecular modeling study of some new phthalazine derivatives
    Authors: FM Awadallah, WI El-Eraky, DO Saleh
    Citation: European Journal of Medicinal Chemistry, 52, 14–21
    Year: 2012
    Citations: 54

  • Title: Genistein ameliorates cyclophosphamide-induced hepatotoxicity by modulation of oxidative stress and inflammatory mediators
    Authors: DF Mansour, DO Saleh, RE Mostafa
    Citation: Open Access Macedonian Journal of Medical Sciences, 5(7), 836
    Year: 2017
    Citations: 52

  • Title: Zeaxanthin Isolated from Dunaliella salina Microalgae Ameliorates Age Associated Cardiac Dysfunction in Rats through Stimulation of Retinoid Receptors
    Authors: FK El-Baz, RA Hussein, DO Saleh, GAR Abdel Jaleel
    Citation: Marine Drugs, 17(5), 290
    Year: 2019
    Citations: 51

  • Title: Cardiorenal protective effect of taurine against cyclophosphamide-induced toxicity in albino rats
    Authors: KA Alhumaidha, DO Saleh, MA Abd El Fattah, WI El-Eraky, H Moawad
    Citation: Canadian Journal of Physiology and Pharmacology, 94(2), 131–139
    Year: 2016
    Citations: 51

  • Title: Ovario-protective effects of genistein against cyclophosphamide toxicity in rats: Role of anti-müllerian hormone and oestradiol
    Authors: DO Saleh, DF Mansour
    Citation: European Journal of Pharmacology, 789, 163–171
    Year: 2016
    Citations: 45

  • Title: Heamatococcus pluvialis ameliorates bone loss in experimentally-induced osteoporosis in rats via the regulation of OPG/RANKL pathway
    Authors: FK El-Baz, DO Saleh, GAA Jaleel, RA Hussein, A Hassan
    Citation: Biomedicine & Pharmacotherapy, 116, 109017
    Year: 2019
    Citations: 44

  • Title: Cisplatin-Induced nephrotoxicity in rats: modulatory role of simvastatin and rosuvastatin against apoptosis and inflammation
    Authors: RE Mostafa, DO Saleh, DF Mansour
    Citation: Journal of Applied Pharmaceutical Science, 8(4), 043–050
    Year: 2018
    Citations: 42